buprenorphine hydrochloride tablet

1 INDICATIONS AND USAGE Buprenorphine sublingual tablets is indicated for the treatment of opioid dependence and is preferred for induction. Buprenorphine sublingual tablets should be used as part of a complete treatment plan to include counseling and psychosocial support. Buprenorphine sublingual tablets contains buprenorphine, a partial opioid agonist, and is indicated for the treatment of opioid dependence and is preferred for induction. ( 1 ) Buprenorphine sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support ( 1 ).

hi-tech pharmacal co., inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] pain` `[4] nausea` `[5] off label use` `[6] headache` `[7] arthralgia` `[8] dyspnoea` `[9] diarrhoea` `[10] rash`

8 years ago

ROUND WHITE logo 8

8 years ago

logo 8 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING Buprenorphine sublingual tablets are supplied in white HDPE bottles. 2 mg - white, round, biconvex uncoated tablets with "2" debossed on one side and a dart "→" debossed on the other side NDC 50383-924-93 30 tablets per bottle 8 mg - white, round, biconvex uncoated tablets with "8" debossed on one side and a dart "→" debossed on the other side NDC 50383-930-93 30 tablets per bottle Storage Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature]. Store buprenorphine sublingual tablets securely and dispose of properly [see Patient Counseling Information ( 17 )].

More pills like ROUND logo 8

Related Pills

buprenorphine hydrochloride tablet

hi-tech pharmacal co., inc.

buprenorphine hydrochloride tablet

hi-tech pharmacal co., inc.

buprenorphine hydrochloride tablet

hi-tech pharmacal co., inc.

buprenorphine hydrochloride tablet

hi-tech pharmacal co., inc.

buprenorphine hydrochloride tablet

hi-tech pharmacal co., inc.

Dexmethylphenidate hydrochloride 24 HR dexmethylphenidate hydrochloride 15 MG Extended Release Oral Capsule

Actavis Pharma, Inc.

Metoprolol Succinate 24 HR metoprolol succinate 100 MG Extended Release Oral Tablet

Watson Pharma, Inc.

guanfacine tablet extended release

actavis pharma, inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site